TP53 and neoplasm: Inactivation of TP53 supported glycolysis by impairing the nuclear translocation of the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH), whose levels increased in the cytosol [112], increasing tumor aggressiveness with a higher activity of anabolic pathways [113].